| January 24, 2012 • Volume 9 / Number 2 |
The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.
- Featured Article: Genetic Abnormality Predicts Treatment Benefit for Patients with Rare
Brain Tumor » - Ovarian Cancer Patients with BRCA Mutations May Fare Better than Non-Carriers »
- Experimental Drug Improves Survival in Previously Treated Metastatic Colorectal Cancer »
- Differences in Estrogen Metabolism May Influence Breast Cancer Risk »
- Epigenetic Study Suggests Possible Treatment for Retinoblastoma »
- Also in the Journals: Before Breast Cancer Surgery, Two Anti-HER2 Drugs May Be
Better than One »
- A Conversation with the NCI Women Scientist Advisors »
- More than a Game: Super Bowl Initiative Helps Scientists Study the "Normal" Breast »
- Staying Alive: New Technique Grows Normal and Cancer Cells Rapidly »
- Targeted Therapies Offer Treatment Options for Advanced Kidney Cancer »
- Featured Clinical Trial: First-in-Humans Study of New Immunotherapy Agent »
Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov. |
Posts
